Corbus Pharmaceuticals Holdings, Inc. (NasdaqCM: CRBP)
Health Care · Biotechnology · US
$4.78
-11.15% today · -67.0% 1Y
Corbus Pharmaceuticals Holdings, Inc. (NasdaqCM: CRBP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $104.06M and employs 36 people.
Over the last twelve months the share price has lost 67.0%, trading between 5.13 and 20.56.
Tweenvest scores Corbus Pharmaceuticals Holdings, Inc. across four factors: quality 36/100, value 50/100. Its strongest factor is value.
CRBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $104.06M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -6.09
- Dividend yield
- —
- Beta (5Y)
- 2.63
- 52-week high
- $20.56
- 52-week low
- $5.13
- Avg volume (3M)
- —
- Shares outstanding
- 19.34M
- Employees
- 36
- Next earnings
- —
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
- ISIN
- US21833P3010
- Founded
- 2009
- Listed since
- Oct 27, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tevogen Inc.NasdaqGM: TVGN | $106.69M | $7.11 | +4.87% |
| Vaxart, Inc.OTCPK: VXRT | $105.65M | $0.43 | -0.59% |
| BioGend Therapeutics Co., Ltd.TPEX: 6733 | $104.60M | NT$24.90 | -0.80% |
| Paradigm Biopharmaceuticals LimitedASX: PAR | $104.36M | AU$— | — |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $103.78M | zł60.00 | -6.25% |
| Shine-On BioMedical Co.,Ltd.TPEX: 6926 | $103.57M | NT$66.50 | -1.04% |
| Bioceltix S.A.WSE: BCX | $102.94M | zł69.60 | -4.53% |
| Kintor Pharmaceutical LimitedSEHK: 9939 | $102.88M | HK$1.64 | -8.91% |
Figures last refreshed Oct 11, 2026.